- Home
- EMX vs TKNO Comparison
EMX vs TKNO Comparison
Compare EMX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMX
- TKNO
- Stock Information
- Founded
- EMX N/A
- TKNO 1996
- Country
- EMX Canada
- TKNO United States
- Employees
- EMX N/A
- TKNO N/A
- Industry
- EMX
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- EMX
- TKNO Health Care
- Exchange
- EMX Nasdaq
- TKNO Nasdaq
- Market Cap
- EMX 338.0M
- TKNO 256.9M
- IPO Year
- EMX N/A
- TKNO 2021
- Fundamental
- Price
- EMX $3.65
- TKNO $4.35
- Analyst Decision
- EMX Strong Buy
- TKNO
- Analyst Count
- EMX 2
- TKNO 0
- Target Price
- EMX $5.38
- TKNO N/A
- AVG Volume (30 Days)
- EMX 447.8K
- TKNO 224.0K
- Earning Date
- EMX 08-11-2025
- TKNO 08-07-2025
- Dividend Yield
- EMX N/A
- TKNO N/A
- EPS Growth
- EMX N/A
- TKNO N/A
- EPS
- EMX 0.04
- TKNO N/A
- Revenue
- EMX $29,864,000.00
- TKNO $38,923,000.00
- Revenue This Year
- EMX $11.08
- TKNO $9.52
- Revenue Next Year
- EMX $3.72
- TKNO $15.20
- P/E Ratio
- EMX $80.97
- TKNO N/A
- Revenue Growth
- EMX N/A
- TKNO 11.40
- 52 Week Low
- EMX $1.59
- TKNO $4.00
- 52 Week High
- EMX $3.66
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- EMX 74.62
- TKNO 43.35
- Support Level
- EMX $3.04
- TKNO $4.22
- Resistance Level
- EMX $3.37
- TKNO $4.94
- Average True Range (ATR)
- EMX 0.12
- TKNO 0.29
- MACD
- EMX 0.03
- TKNO -0.00
- Stochastic Oscillator
- EMX 97.58
- TKNO 16.75
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.